China News Service, October 16 According to a report by South American Overseas Chinese News on the 15th, the Peruvian Ministry of Health recently announced that it would stop using azithromycin, ivermectin and hydroxychloroquine to treat hospitalized patients with new coronary pneumonia.
According to reports, the Peruvian Ministry of Health stated that a study published by the Peruvian Health Technology Evaluation and Research Institute showed that within 48 hours of the use of azithromycin, ivermectin and hydroxychloroquine in hospitalized patients with new coronary pneumonia, these three drugs were reducing Mortality, intensive care unit occupancy rate and oxygen demand have not seen obvious effects. Therefore, the Ministry of Health has decided to stop using these three drugs for hospitalized patients with the new crown.
Earlier, Peru’s Minister of Health, Soler, announced that azithromycin and hydroxychloroquine would no longer be distributed to patients with new crowns. In addition, hydroxychloroquine is only allowed to be used to treat certain types of patients with new crowns.
Soler also emphasized that “there is currently no specific medicine for the treatment of new coronary pneumonia in the world, and the medicines we have can only treat symptoms that occur after infection.”